Skip to main content
OpenTrials

Clinical trial condition

Glomerulonephritis, IGA

Explore clinical trials studying Glomerulonephritis, IGA. Study availability and eligibility vary by location and protocol.

203 public trials 59 recruiting studies
Refine in advanced search Browse all conditions

Glomerulonephritis, IGA trial results

Active, not recruiting

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

NCT06291376

Conditions
Autoimmune Diseases, Chronic Disease, Disease Attributes, +20 more
Locations
  • Research Site Alabaster, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Los Angeles, California, United States
View all 246 locations
View Trial Details
Active, not recruiting

Atrasentan in Patients With IgA Nephropathy

NCT04573478

Conditions
Autoimmune Diseases, Chronic Disease, Disease Attributes, +16 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Comprehensive Research Institute Alhambra, California, United States
  • Kidney Disease Medical Group Glendale, California, United States
  • Stanford University Stanford, California, United States
View all 135 locations
View Trial Details
Active, not recruiting

Atrasentan in Patients With Proteinuric Glomerular Diseases

NCT04573920

Conditions
Alport Syndrome, Autoimmune Diseases, Collagen Diseases, +26 more
Locations
  • Kidney Disease Medical Group Glendale, California, United States
  • Academic Medical Research Institute Los Angeles, California, United States
  • North America Research Institute San Dimas, California, United States
  • Stanford U School Of Medicine Stanford, California, United States
View all 33 locations
View Trial Details
Active, not recruiting

Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

NCT06564142

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Apogee Clinical Research, LLC Huntsville, Alabama, United States
  • Arizona Kidney Disease and Hypertension Center - Thomas Office Phoenix, Arizona, United States
  • Arizona Kidney Disease and Hypertension Center - Tuscon Tucson, Arizona, United States
  • West Coast Kidney Fremont, California, United States
View all 318 locations
View Trial Details
Active, not recruiting

A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy

NCT03762850

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Travere Investigational Site Birmingham, Alabama, United States
  • Travere Investigational Site Homewood, Alabama, United States
  • Travere Investigational Site Glendale, California, United States
  • Travere Investigational Site Montebello, California, United States
View all 162 locations
View Trial Details
Active, not recruiting

A Study of Zigakibart in Adults With IgA Nephropathy

NCT05852938

Conditions
Autoimmune Diseases, Chronic Disease, Disease Attributes, +16 more
Locations
  • University of Alabama at Birmingham: The Kirklin Clinic Birmingham, Alabama, United States
  • Nephrology Consultants, LLC Huntsville, Alabama, United States
  • University of California, San Francisco San Francisco, California, United States
  • Valiance Clinical Research South Gate, California, United States
View all 200 locations
View Trial Details
Active, not recruiting

A Study of Telitacicept for IgA Nephropathy (TELIGAN)

NCT05799287

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • The First Affiliated Hospital of Bengbu Medical University Bengbu, Anhui, China
  • The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital) Hefei, Anhui, China
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
View all 101 locations
View Trial Details
Active, not recruiting

An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases

NCT05732402

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +38 more
Locations
  • Investigational Site (523) Phoenix, Arizona, United States
  • Investigational Site (501) Phoenix, Arizona, United States
  • Investigational Site (524) Tucson, Arizona, United States
  • Investigational Site (506) Valencia, California, United States
View all 30 locations
View Trial Details

Related conditions